Melanotan I (MT-1)
Melanotan I (afamelanotide) is a synthetic analog of alpha-melanocyte-stimulating hormone studied in pigmentation pathway research.
We have not published an audit on Melanotan I (MT-1). Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for Melanotan I (MT-1) or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| 0.16 mg/kg daily (injection protocol); 16 mg implant every 2 months (approved) | Daily for 10 days per10-day injection | subcutaneous or oral | Peptide Protocol WikiWhat it saysHide(secondary reference; provider confirmation required). |
- Daily for 10 days per10-day injection
- subcutaneous or oral
- Peptide Protocol Wiki
What it saysHide
(secondary reference; provider confirmation required).
- Sterile water
The reference sections above are imported from our compound knowledge base, which classes the evidence for Melanotan I (MT-1) as emerging. That classification is the knowledge base’s, not ours, our own grade appears only where an audit is linked above. Research use only; nothing here is medical advice or a protocol.
5-Amino-1MQ is a small molecule studied for its potential to help the body shrink fat cells and raise NAD+ levels without cutting appetite.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Studied in tissue-repair and regeneration research models.
Peptide bioregulator referenced for connective tissue support.
Peptide bioregulator referenced for nervous system support.
Combination research blend of CJC-1295 (no DAC) and Ipamorelin. Studied as a GHRH/GHRP combination in growth-hormone-axis research.
Peptide bioregulator referenced for pineal support.